MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$2,966,336
EPS
-$0.73
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Sales
-820,188 1,120,121 1,888,838.5*
Cost of sales
-635,994 716,962 922,372*
Gross profit
-184,194 403,159 966,466.5*
Research and development
1,022,630 630,636 581,612 540,380*
General and administrative
1,742,016 1,621,095 1,532,015 5,906,910.5*
Amortization and depreciation
51,707 53,201 53,202 49,102*
Foreign exchange loss
-23,168 18,136 -56,994 -7,117.75*
Total operating expenses
2,839,521 2,286,796 2,223,823 6,503,510.25*
Interest and other income
47,770 74,379 93,765 -15,400*
Finance expense
---92,887.25*
Net loss from continuing operations before taxes
-2,791,751 -2,028,223 -1,726,899 -5,645,331
Net loss from continuing operations
-2,791,751 ---
Income (loss) from discontinued operations
-174,585 ---
Loss from discontinued operations
-174,585 ---
Net loss
-2,966,336 -2,028,223 -1,726,899 -5,645,331
Basic EPS
-0.73 -0.51 -0.44 -5.784
Diluted EPS
-0.73 -0.51 -0.44 -5.784
Basic Average Shares
4,048,209 3,954,549 3,954,549 975,985*
Diluted Average Shares
4,048,209 3,954,549 3,954,549 975,985*
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$2,966,336 Net loss fromcontinuing operations-$2,791,751 Loss fromdiscontinued operations-$174,585 Net loss fromcontinuing operations...-$2,791,751 Income (loss) fromdiscontinued operations-$174,585 Interest and other income$47,770 Total operatingexpenses$2,839,521 General andadministrative$1,742,016 Research and development$1,022,630 Amortization anddepreciation$51,707 Foreign exchange loss-$23,168

InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Inc. (INM)